Clinical Trials Browser

Interventional × Lymphatic Metastasis × Thoracic × Clear all

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT06252129 2026-03-05

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Phase NA Recruiting

160 enrolled

Thoracic

Lung Neoplasms, Lymphatic Metastasis, Pathologic Processes

NCT07162883 2025-09-09

Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Not yet recruiting

122 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04233476 2024-07-01

TRIIL

Phase 3 Completed

409 enrolled

Thoracic

Lung Neoplasms, Lymphatic Metastasis

NCT06031246 2023-09-11

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Phase 3 Recruiting

634 enrolled

Thoracic

Adenocarcinoma of Lung, Lymphatic Metastasis

NCT02341170 2019-04-17

HIPPO-S

Phase NA Withdrawn

Thoracic

Adenocarcinoma, Lung Neoplasms, Lymphatic Metastasis

Clinical Trials

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)

TRIIL

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

HIPPO-S